Medis Medical imaging is celebrating the 100th published peer-reviewed manuscript on our Quantitative Flow Ratio (QFR®) solution. QFR® is the innovative technology allowing for the non-invasive assessment of functional significant coronary lesions, without the use of adenosine or pressure wires. With the roll-out of the QFR solution, we see more and more papers being published in different patient populations, from many sites around the globe, featuring new ideas and gearing towards the extensive use in daily clinical practice. As a result, the number of publications are expected to continue to increase week by week, which we are very proud of and indebted to the great work of all these researchers and clinicians who do their utmost to come up with these exciting ideas and applications.
The 100th published paper, based on our registration, was the one by Dr Cai and colleagues from the Department of Cardiology, PLA General Hospital, Beijing, China and is recently accepted in the Catheterization and Cardiovascular Interventions Journal (click here)
Certainly by the work of all the authors from the 100 papers and many more abstracts, posters and presentations, we are very motivated to continue to be a thought leader in the field of cardiovascular imaging. We are proud of our heritage and that we are able to, continuously, develop tools that provide the healthcare professional with more extensive and quantitative physiological imaging results.
QFR® provides the healthcare professional with more extensive and quantitative physiologic imaging results to support the patient’s treatment in the interventional cardiology diagnostic and treatment pathway. The QFR® analysis is performed during the interventional procedure and can streamline workflow in the cath lab while driving economic value. Unlike traditional invasive assessments, including FFR and iFR, the QFR® analysis output, including 3D QCA, is intrinsically registered with the angiogram and automatically identifies and prioritizes any functionally significant coronary obstructions, and also provides prognostic information.
Learn more on QFR®: www.medisimaging.com/qfr
